» Articles » PMID: 11466410

Inflammatory Genes Are Upregulated in Expanded Ataxin-3-expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains

Overview
Journal J Neurosci
Specialty Neurology
Date 2001 Jul 24
PMID 11466410
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine disorder caused by a CAG repeat expansion in the coding region of a gene encoding ataxin-3. To study putative alterations of gene expression induced by expanded ataxin-3, we performed PCR-based cDNA subtractive hybridization in a cell culture model of SCA3. In rat mesencephalic CSM14.1 cells stably expressing expanded ataxin-3, we found a significant upregulation of mRNAs encoding the endopeptidase matrix metalloproteinase 2 (MMP-2), the transmembrane protein amyloid precursor protein, the interleukin-1 receptor-related Fos-inducible transcript, and the cytokine stromal cell-derived factor 1alpha (SDF1alpha). Immunohistochemical studies of the corresponding or associated proteins in human SCA3 brain tissue confirmed these findings, showing increased expression of MMP-2 and amyloid beta-protein (Abeta) in pontine neurons containing nuclear inclusions. In addition, extracellular Abeta-immunoreactive deposits were detected in human SCA3 pons. Furthermore, pontine neurons of SCA3 brains strongly expressed the antiinflammatory interleukin-1 receptor antagonist, the proinflammatory cytokine interleukin-1beta, and the proinflammatory chemokine SDF1. Finally, increased numbers of reactive astrocytes and activated microglial cells were found in SCA3 pons. These results suggest that inflammatory processes are involved in the pathogenesis of SCA3.

Citing Articles

Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort study.

Ye Z, Chen X, Li M, Chen X, Qiu Y, Yuan R Orphanet J Rare Dis. 2025; 20(1):35.

PMID: 39849568 PMC: 11761751. DOI: 10.1186/s13023-025-03531-8.


ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.

Hernandez-Carralero E, Quinet G, Freire R Expert Rev Mol Med. 2024; 26:e19.

PMID: 39320846 PMC: 11440613. DOI: 10.1017/erm.2024.10.


Treatment of neurological pathology and inflammation in Machado-Joseph disease through in vivo self-assembled siRNA.

Li Z, Du X, Yang Y, Zhang L, Chen P, Kan Y Brain. 2024; 148(3):817-832.

PMID: 39315766 PMC: 11884698. DOI: 10.1093/brain/awae304.


The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.

Potapenko A, Davidson J, Lee A, Laird A Biochem J. 2024; 481(6):461-480.

PMID: 38497605 PMC: 11088879. DOI: 10.1042/BCJ20240017.


Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3.

Duarte-Silva S, Da Silva J, Monteiro-Fernandes D, Costa M, Neves-Carvalho A, Raposo M J Clin Invest. 2024; 134(5).

PMID: 38227368 PMC: 10904051. DOI: 10.1172/JCI162246.


References
1.
Roher A, Kasunic T, Woods A, Cotter R, Ball M, Fridman R . Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun. 1994; 205(3):1755-61. DOI: 10.1006/bbrc.1994.2872. View

2.
Perez M, Paulson H, Pendse S, Saionz S, Bonini N, Pittman R . Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol. 1998; 143(6):1457-70. PMC: 2132986. DOI: 10.1083/jcb.143.6.1457. View

3.
Shivers B, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg P . Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 1988; 7(5):1365-70. PMC: 458385. DOI: 10.1002/j.1460-2075.1988.tb02952.x. View

4.
Warrick J, Chan H, Chai Y, Paulson H, Bonini N . Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 1999; 23(4):425-8. DOI: 10.1038/70532. View

5.
Wullner U, Kornhuber J, Weller M, Schulz J, Loschmann P, Riederer P . Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol. 1999; 97(4):408-12. DOI: 10.1007/s004010051005. View